Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

ZTS Zoetis Inc

Price (delayed)

$163.04

Market cap

$72.59B

P/E Ratio

29.22

Dividend/share

$1.86

EPS

$5.58

Enterprise value

$77.62B

Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's ...

Highlights
The P/E is 26% lower than the 5-year quarterly average of 39.3 and 10% lower than the last 4 quarters average of 32.5
Zoetis's EPS has increased by 8% YoY and by 2% QoQ
Zoetis's quick ratio has decreased by 47% YoY and by 6% QoQ
ZTS's equity is down by 8% year-on-year and by 2.4% since the previous quarter

Key stats

What are the main financial stats of ZTS
Market
Shares outstanding
445.21M
Market cap
$72.59B
Enterprise value
$77.62B
Valuations
Price to earnings (P/E)
29.22
Price to book (P/B)
15.68
Price to sales (P/S)
7.86
EV/EBIT
22.78
EV/EBITDA
19.92
EV/Sales
8.36
Earnings
Revenue
$9.29B
Gross profit
$6.59B
Operating income
$3.42B
Net income
$2.52B
EBIT
$3.41B
EBITDA
$3.9B
Free cash flow
$2.28B
Per share
EPS
$5.58
EPS diluted
$5.57
Free cash flow per share
$5.1
Book value per share
$10.4
Revenue per share
$20.75
TBVPS
$23.01
Balance sheet
Total assets
$14.1B
Total liabilities
$9.44B
Debt
$6.75B
Equity
$4.66B
Working capital
$2.49B
Liquidity
Debt to equity
1.45
Current ratio
1.74
Quick ratio
0.91
Net debt/EBITDA
1.29
Margins
EBITDA margin
42%
Gross margin
70.9%
Net margin
27.1%
Operating margin
36.8%
Efficiency
Return on assets
17.7%
Return on equity
51.3%
Return on invested capital
26.7%
Return on capital employed
31.8%
Return on sales
36.7%
Dividend
Dividend yield
1.14%
DPS
$1.86
Payout ratio
33.4%

ZTS stock price

How has the Zoetis stock price performed over time
Intraday
1.68%
1 week
2.37%
1 month
11.09%
1 year
-6.14%
YTD
0.07%
QTD
-0.98%

Financial performance

How have Zoetis's revenue and profit performed over time
Revenue
$9.29B
Gross profit
$6.59B
Operating income
$3.42B
Net income
$2.52B
Gross margin
70.9%
Net margin
27.1%
ZTS financials
The gross profit has grown by 8% YoY
ZTS's revenue is up by 6% YoY
Zoetis's operating income has increased by 6% YoY
The net income has grown by 5% YoY

Price vs fundamentals

How does ZTS's price correlate with its fundamentals
Price vs fundamentals
Earnings waterfall
Price vs fair value

Growth

What is Zoetis's growth rate over time
ZTS growth chart

Valuation

What is Zoetis stock price valuation
P/E
29.22
P/B
15.68
P/S
7.86
EV/EBIT
22.78
EV/EBITDA
19.92
EV/Sales
8.36
Valuation vs average
Price to earnings (P/E)
The P/E is 26% lower than the 5-year quarterly average of 39.3 and 10% lower than the last 4 quarters average of 32.5
Zoetis's EPS has increased by 8% YoY and by 2% QoQ
Price to book (P/B)
The stock's price to book (P/B) is 14% less than its 5-year quarterly average of 18.2 and 2% less than its last 4 quarters average of 16.0
ZTS's equity is down by 8% year-on-year and by 2.4% since the previous quarter
Price to sales (P/S)
ZTS's price to sales (P/S) is 23% lower than its 5-year quarterly average of 10.2 and 9% lower than its last 4 quarters average of 8.6
ZTS's revenue is up by 6% YoY

Efficiency

How efficient is Zoetis business performance
ZTS's ROIC is up by 9% YoY and by 4.3% QoQ
The company's return on equity rose by 6% YoY and by 3.2% QoQ
ZTS's return on assets is up by 4.7% year-on-year

Dividends

What is ZTS's dividend history
DPS
$1.86
Dividend yield
1.14%
Payout ratio
33.4%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Zoetis financials performed over time
Assets vs liabilities
ZTS's total assets is 49% greater than its total liabilities
The company's current ratio fell by 48% YoY
Zoetis's quick ratio has decreased by 47% YoY and by 6% QoQ
Debt vs equity
The debt is 45% higher than the equity
Zoetis's debt to equity has increased by 8% YoY and by 2.8% QoQ
ZTS's equity is down by 8% year-on-year and by 2.4% since the previous quarter
Balance sheet

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.